The Nanotechnology in Medical Devices Market in Europe is currently estimated at USD 1618 Million in 2020 and is poised to reach USD 2940 Million by 2025, growing at a CAGR of 12.7% from 2020 to 2025.
The significant growth rate is attributed to the technological advancements, rising prevalence of the aging population resulting in increased incidences of diseases. There is increased optimism about the ability of nanotechnology-based medical devices to reform the healthcare industry.
Nanotechnology involves the use of nano-robots to repair at the cellular level involving the dimension that are tiny fractions of the human hair. With many nanotechnology-based applications at various testing stages, it offers exciting opportunities and is believed to revolutionize the treatment for the human body in the future.
The market is driven by a list of factors that include rising investments in research and development of nanotechnology with international collaboration, rising aging population, increasing awareness, growing expenditure with the increased availability of insurance coverage and reimbursement. However, few factors hamper the market's growth include high costs involving nanotechnology devices and stringent regulatory policies.
This research report on the European Nanotechnology in Medical Devices Market has been segmented and sub-segmented into the following categories:
By Product:
By Application:
By Country:
Leading companies in the Europe Nanotechnology in Medical Devices Market profiled in the report are AMAG pharmaceuticals, Jude Medical, Inc., Smith & Nephew, Inc., PerkinElmer, Inc., Acusphere, Inc., 3M Company, Affymetrix, Inc., Starkey Hearing Technologies, and Stryker Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modeling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 U.K
6.2 Spain
6.3 Germany
6.4 Italy
6.5 France
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
